FBLN1 and hyperlipidemia: Interestingly, the signal variation of mean plasma fibulin-1 between the high arterialficant stiffness group and normal arterial stiffness group persisted after adjusting for age, SBP, DBP, MAP, PP, FBG, TG, TC, HDL-C, LDL-C, Type 2 diabetes, and hyperlipidemia (12.69 ± 0.89 vs. 9.84 ± 0.71 μg/ml, p < 0.05; Table 2).